N.v. Tyagarajan compensation by year
Genpact Summary Compensation Table · all 3 fiscal years held| Component | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Salary | $824,000 | $900,000 | $95,690 |
| Bonus | $0 | $0 | $0 |
| Stock awards | $2,252,530 | $8,052,254 | $0 |
| Option awards | $0 | $0 | $0 |
| Non-equity incentive | $1,023,000 | $967,559 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $67,253 | $67,533 | $39,094 |
| Total | $4,166,783 | $9,987,346 | $134,784 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Genpact LTD DEF 14A filed April 9, 2025, accession 0001140361-25-013031, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Genpact LTD filed document, accession 0001140361-25-013031. Every figure is read from that document and cited to the page and table it appears in. Filed April 9, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 91,680 | $3,937,656 | — |
| RSU | 91,311 | $3,921,807 | — |
| RSU | 61,120 | $2,625,104 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Genpact LTD's FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments Genpact discloses, by trigger · FY2023| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Retirement | $0 | $2,121,475 | $0 | $2,121,475 |
| Involuntary termination without cause | $3,846,000 | $0 | $35,614 | $3,881,614 |
| Death | $0 | $8,158,893 | $0 | $8,158,893 |
| Resignation for good reason, no change in control | $3,846,000 | $0 | $35,614 | $3,881,614 |
| Change in control and involuntary termination | — | $13,458,321 | — | $13,458,321 |
| Involuntary for cause | $0 | $0 | $0 | $0 |
| Disability | $0 | $8,158,893 | $0 | $8,158,893 |
Per the Potential Payments Upon Termination or Change in Control table in Genpact LTD's FY2023 proxy. Estimates as the company printed them; a dash means it printed no figure.
Genpact’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Balkrishan Kalra | President, Chief Executive Officer and Director | $10,879,462 |
| Michael Weiner | Senior Vice President, Chief Financial Officer | $6,452,049 |
| Riju Vashisht | Senior Vice President, Chief Growth Officer and Global Business Leader, Enterprise Services and Partnerships and Alliances | $5,958,769 |
| Piyush Mehta | Senior Vice President, Chief Human Resources Officer and Country Manager, India | $5,905,402 |
| Anil Nanduru | Senior Vice President, Global Business Leader, Consumer & Healthcare and High Tech & Manufacturing | $5,863,913 |
| N.v. Tyagarajan · this page | Former President and Chief Executive Officer and current Director | $134,784 |
Board service
Genpact board · FY2023–FY2025| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $27,500 | — | $0 | $0 | $27,500 |
| FY2024 | $62,500 | $209,996 | — | $0 | $272,496 |
| FY2023 | $0 | $0 | $0 | $0 | — |
Each year as the company reported it in Genpact's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: Genpact pays directors a $70,000 cash retainer and $210,000 in equity. As stated in Genpact's FY2025 proxy.
The full Genpact compensation record
free company briefThis page is one person within Genpact's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Genpact proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Genpact's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.